Bicara Therapeutics

Flexibility and adaptation concept Arrows on cubes following a flexible path
Biotech

'One of the lucky few': Bicara CEO on last year's $326M IPO

“We continue to operate as if we're in a world where financings are hard to achieve,” CEO Claire Mazumdar said after Bicara's $362 million 2024 IPO.
Gabrielle Masson Apr 14, 2025 3:59pm
Court lawsuit legal litigation

Biocon accused of IP theft to create cancer biotech Bicara

Oct 24, 2024 11:04am
Graphic image of the letters IPO in white in front of a yellow background

Zenas, MBX, Bicara head to Nasdaq in hot day for biotech IPOs

Sep 13, 2024 5:25am
IPO initial public offering Wall Street

Zenas, Bicara set out to raise $180M-plus in separate IPOs

Sep 6, 2024 8:18am
IPO initial public offering markets raise financing

Bicara, Zenas seek IPOs to push late-phase assets toward market

Aug 23, 2024 5:07am
dollars money ocean dollar bill

Bicara raises second $100M+ round of 2023, closing new series C

Dec 12, 2023 6:30am